Epstein-Barr viremia and post-transplant lymphoproliferative disorders in patients undergoing haploidentical stem cell transplantation with post-transplant cyclophosphamide

Abstract excerpt

To the Editor, Historically, haploidentical hematopoietic stem cell transplant (haplo-HSCT) protocols have utilized intensive immunosuppression strategies to overcome the bidirectional alloreactivity [1].However, this results in high risk of infectious complications such as Epstein-Barr virus (EBV) viremia and post-transplant lymphoproliferative disorders (PTLD) [2,3].T-cell replete haplo-HSCT utilizing...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hematopoietic Stem Cell Transplantation
• Share to Polyomavirus and related diseases
• Share to Viral-associated cancers and disorders